Semaglutide (Injectable) in New Mexico

Pepti serves all of New Mexico. A physician licensed in New Mexico reviews every order within 24 hours, the prescription is compounded by a state-licensed, FDA-registered pharmacy, and it ships free and tracked to any New Mexico street address. The price is the same as every other state.

Yes. The whole process is online in New Mexico: a free assessment, physician review, messaging, dose changes, and refills through your Pepti account or the Hello Pepti app. No clinic visit is required.

Pepti ships Semaglutide to New Mexico directly from the pharmacy: free, tracked, unbranded, in insulated packaging with ice packs for refrigerated medication. The pharmacy compounds in 1-3 business days and delivery takes 1-3 business days after shipment. PO Boxes are not accepted.

Every treatment on Pepti's catalog ships to New Mexico. Eligibility is confirmed during the assessment from your New Mexico shipping address, and if anything ever cannot ship to your address it is refunded.

The same as everywhere Pepti serves: one all-in monthly price per treatment that includes the medication, the physician, and shipping, with no New Mexico-specific markup and no membership or consult fee. Every price is on the product page.

Yes. Pepti's physicians hold licenses in New Mexico, and only a physician licensed where you live reviews and prescribes your order. Their names and credentials are on the providers page.

Yes. Pepti's partner pharmacies are state-licensed, FDA-registered 503A compounding pharmacies licensed to dispense into New Mexico, and every batch is independently tested before it ships.

GLP-1 receptor agonist prescribed for medical weight management under licensed physician supervision. Compounded; not FDA-approved. Semaglutide is prescription-only at Pepti: a licensed physician reviews your assessment and, if appropriate, prescribes it to be compounded by a state-licensed, FDA-registered pharmacy.

Semaglutide is commonly prescribed for: Adults with a BMI in the range their physician considers appropriate for GLP-1 therapy; Patients who have struggled with appetite and weight despite diet and exercise; People who want physician-managed dose escalation rather than a fixed dose; Patients already on semaglutide who want to continue at their current dose. Whether it is appropriate for you is decided by the reviewing physician from your history, medications, and labs where required.

Yes. Semaglutide is prescription-only. The free online assessment takes about five minutes, a physician licensed in New Mexico reviews it within 24 hours, and if approved the prescription goes to the pharmacy. If not approved, the medication charge is refunded.

Yes. Semaglutide is one of the medications Pepti requires recent bloodwork for before it is prescribed. Upload a recent lab report from any lab, or order Pepti's at-home panel; the physician reviews the results with your assessment.

Semaglutide is a subcutaneous injection into the abdomen or thigh with a small insulin syringe. Your kit ships with sterile syringes and alcohol prep pads, and the exact dose and schedule are printed on the pharmacy label. Dosing videos are in your account.

One vial is your monthly supply at the dose your physician prescribes. A fresh vial ships about every 28 days, and the date moves if your physician changes your dose. Store it as the pharmacy label directs, refrigerated.

Once per fill, $99 each time, when the next vial ships. It renews until you cancel, which you can do anytime from your account with no cancellation fee.

The compounded Semaglutide with sterile syringes and alcohol prep pads, free tracked shipping in an unbranded box with insulated packaging, the physician review, ongoing physician care and dose adjustments, and unlimited messaging.

Reported side effects of Semaglutide are usually mild: nausea (most common, especially first 2 weeks); constipation or diarrhea; fatigue; heartburn; reduced appetite (this is the goal). The physician screens your history, medications, and allergies before prescribing, the medication-specific consent lists the known risks, and you can message your physician about anything you notice. Seek emergency care for severe symptoms.

Response varies by person, goal, and dose, and Semaglutide is prescribed for ongoing use rather than a short trial. Your physician sets expectations at approval, tracks how you respond through your account, and adjusts the dose without an appointment.

Yes, one step at a time. Semaglutide moves up the pharmacy's strength ladder when your physician approves, and you pay the cost difference for the higher strength. It is never doubled.

Yes. Add Semaglutide to a plan with another treatment and both go through one assessment and one physician review, shipping together on one schedule. Each keeps its own catalog price. The physician reviews the combination and can adjust it.

Compounded Semaglutide is not FDA-approved. A brand-name form of the active ingredient is FDA-approved for specific indications; Pepti's version is compounded to your physician's prescription by an FDA-registered 503A pharmacy and prescribed off-label.

Yes, when prescribed by a licensed physician and dispensed by a licensed pharmacy, which is how Pepti provides it in New Mexico. Research-use-only Semaglutide sold without a prescription is labeled not for human use and is a different product.

Semaglutide is a GLP-1 receptor agonist that mimics the body's natural incretin hormone. At Pepti it is prescribed to support appetite control, significant weight loss, blood sugar support, cardiovascular health. Individual response varies, and your physician sets expectations at approval.

Semaglutide is a GLP-1 receptor agonist that mimics the body's natural incretin hormone. It slows gastric emptying, reduces appetite at the hypothalamic level, and improves insulin sensitivity. Clinical trials show 15-20% body weight loss over 68 weeks. Compounded Semaglutide is not FDA-approved; it is prescribed off-label by a licensed physician after reviewing your assessment.

Semaglutide is prescribed for appetite control, significant weight loss, blood sugar support, cardiovascular health. It is commonly requested by adults with a BMI in the range their physician considers appropriate for GLP-1 therapy; patients who have struggled with appetite and weight despite diet and exercise; people who want physician-managed dose escalation rather than a fixed dose; patients already on semaglutide who want to continue at their current dose. Whether it is appropriate for you is the reviewing physician's decision.

Semaglutide is studied for appetite control, significant weight loss, blood sugar support, cardiovascular health. Those are the goals it is prescribed to support at Pepti; results vary by person, dose, and consistency, and no outcome is guaranteed. Your physician tracks how you respond through your account.

The landmark STEP 1 trial (Wilding et al., NEJM 2021) randomized 1,961 adults with obesity to weekly subcutaneous semaglutide 2.4 mg vs placebo. After 68 weeks, the semaglutide arm achieved a mean weight loss of 14.9% of body weight compared to 2.4% on placebo. The SUSTAIN program demonstrated significant HbA1c reduction in type 2 diabetes, and the SELECT trial (2023) extended the evidence to cardiovascular outcomes — semaglutide reduced major adverse cardiovascular events by 20% in overweight or obese adults with established cardiovascular disease. Compounded semaglutide uses the identical active pharmaceutical ingredient prepared by FDA-registered 503A pharmacies. References are listed on this page.

Semaglutide is generally not prescribed with: active cancer or history of cancer (unless approved by oncologist); pregnancy or breastfeeding; severe kidney or liver disease; known allergy to the peptide or excipients; personal or family history of medullary thyroid cancer; multiple endocrine neoplasia syndrome type 2; pancreatitis history. The physician screens for these in your intake, and anything that rules Semaglutide out means it is not prescribed and is refunded.

At Pepti. Complete the free assessment, a physician licensed in New Mexico reviews it within 24 hours, and if appropriate Semaglutide is compounded by a state-licensed, FDA-registered pharmacy and shipped free to your door for $99 per month, all-in. Not prescribed means refunded.

Injectable vial: 1 to 3 mL, sized to your dose, containing compounded to your dose Semaglutide. One vial is your monthly supply at the prescribed dose, and a fresh one ships about every 28 days.

Not currently. Semaglutide ships as a multi-dose vial with sterile syringes and prep pads. The pepti Pen is available for 10 other treatments.

$99 per month covers the compounded Semaglutide, the physician review, ongoing physician care including dose adjustments and refill review, unlimited messaging, and free tracked shipping. There is no membership, consult, visit, or refill fee; the only separate charges are optional at-home lab panels and a physician-approved dose increase billed at pharmacy cost.

Yes. Semaglutide is on Pepti's live catalog, which lists only treatments a partner pharmacy can compound and ship today. If a physician prescribes it, it ships; if it ever cannot be dispensed, the charge is refunded.

Semaglutide ships to all 50 states and Washington, D.C, free and tracked, in insulated unbranded packaging. Eligibility is confirmed during the assessment from your shipping address.